In this case-based activity, Drs. Craig Lammert and David Assis, leaders of the AASLD Cholestatic and Autoimmune Liver Disease SIG, discuss two newly approved therapies for patients with primary biliary cholangitis. They will explore a variety of patient scenarios involving the diagnosis and treatment of patients with PBC to explore the range of available therapies, and how best to approach each clinical encounter.
- Provider:American Association for the Study of Liver Diseases
- Activity Link: https://liverlearning.aasld.org/URL/NewTreamentsinPBC
- Start Date: 2024-09-23 05:00:00
- End Date: 2024-09-23 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- MOC Credit Details: ABIM - 0.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Gastroenterology, Transplant Hepatology
Subscribe
Login
0 Comments
Oldest